US Stocks
/
Palvella Therapeutics, Inc. Share Price
Palvella Therapeutics, Inc. Share Price

Palvella Therapeutics, Inc. Share Price

NASDAQ: PVLA | Small Cap
$151.49
-$0.06 (-0.04%) Last updated on 16 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Palvella Therapeutics, Inc. Stock Performance

Open
$150.97
Prev. Close
$151.55
Circuit Range
N/A
Day Range
$148.50 - $151.92
Year Range
$53.50 - $160.05
Volume
17,082
Average Traded
$149.73

Palvella Therapeutics, Inc. Share Price Today

As of 16 September 2026, Palvella Therapeutics, Inc.'s share price is $151.49. The stock opened at $150.97, compared to its previous close of $151.55. During today's trading session, Palvella Therapeutics, Inc.'s share price traded between $148.50 and $151.92, with an average price of $150.21. Over the past 52 weeks, the stock has recorded a high of $160.05 and a low of $53.50. In terms of performance, Palvella Therapeutics, Inc.'s share price has risen by 21.19% over the last six months and is up 141.86% on a year-on-year basis.

Palvella Therapeutics, Inc. Share Price Chart

$148.50$151.92
L
Show Current Price
H

Palvella Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.70B
PE Ratio (TTM)
-40.83
Dividend Yield
N/A
EPS (TTM)
$-3.71
Revenue (TTM)
$25.90M
Return On Equity (TTM)
-149.07%
Profit Margin
-161.05%
Debt to Equity
0.41
Quarterly Earnings Growth YoY
-67.31%

Palvella Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025
RevenueN/A$0.00$0.00N/A
Net Profit-$4.89M-$3.59M-$2.89M-$8.19M
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A26.61%19.58%-183.51%

Palvella Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202220242025
Revenue$25.90MN/AN/A
Net Profit-$33.28M-$17.43M-$41.72M
Net Profit Margin-128.47%N/AN/A
Income ChangeN/A47.61%-139.27%

About Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN 3.9% rapamycin anhydrous gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania

Palvella Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$150.16
$151.55
+0.94%
Aug 2026
$137.99
$150.14
+7.82%
Jul 2026
$149.11
$139.25
-9.06%
Jun 2026
$115.47
$153.13
+29.64%
May 2026
$129.47
$118.12
-7.93%
Apr 2026
$129.50
$128.30
+2.64%
Mar 2026
$139.98
$125.00
-7.84%
Feb 2026
$78.81
$135.63
+76.90%
Jan 2026
$100.00
$76.67
-26.39%
Dec 2025
$96.25
$104.16
+0.84%
Nov 2025
$80.00
$103.29
+29.12%
Oct 2025
$62.41
$80.00
+27.72%

PVLA Share Price FAQs

What is Palvella Therapeutics, Inc. share price today?

chevron-up
Palvella Therapeutics, Inc. share price today is $151.49 as on September 16, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Palvella Therapeutics, Inc. stock?

chevron-up
The 52 week high of Palvella Therapeutics, Inc. stock is $160.05, while the 52 week low is $53.50 as of 16 Sep '26.

What is PVLA's market capitalisation today?

chevron-up
PVLA market capitalisation is $1.70B as of September 16, 2026, at 9:10 am IST.

What is PVLA's net income for the last quarter?

chevron-up
PVLA's net income for the last quarter is -0.01B USD.

What is the 5 year returns of PVLA?

chevron-up
The 5 year returns of PVLA is -63.37% as on 16 Sep '26.

What is the high & low stock price of PVLA today?

chevron-up
PVLA stock price hit a high of $151.92 and low of $148.50 as of 16 Sep '26.

Can I buy PVLA shares in India?

chevron-up
Yes. You can buy PVLA in India by opening an international trading account.